Expression levels of estrogen receptor (ER) gene and three ER-related genes in metastatic ER-positive breast cancer compared with response to endocrine therapy.

被引：0
|
作者：
Lai, S [1 ]
Valero, V [1 ]
Booster, D [1 ]
Fiterman, DJ [1 ]
Pusztai, L [1 ]
Symmans, WF [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [1] Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
    Iwamoto, Takayuki
    Booser, Daniel
    Valero, Vicente
    Murray, James L.
    Koenig, Kimberly
    Esteva, Francisco J.
    Ueno, Naoto T.
    Zhang, Jie
    Shi, Weiwei
    Qi, Yuan
    Matsuoka, Junji
    Yang, Elliana J.
    Hortobagyi, Gabriel N.
    Hatzis, Christos
    Symmans, W. Fraser
    Pusztai, Lajos
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (07) : 729 - 734
  • [2] Correlations of estrogen receptor (ER) related genomic transcription and ER gene expression with increasing AJCC stage of ER-positive breast cancer
    Andreopoulou, E.
    Hatzis, C.
    Booser, D.
    Valero, V.
    Wallace, M. J.
    Sotiriou, C.
    Hortobagyi, G.
    Pusztai, L.
    Symmans, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment
    Tang, Jianing
    Cui, Qiuxia
    Zhang, Dan
    Liao, Xing
    Zhu, Jian
    Wu, Gaosong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (08) : 4980 - 4990
  • [4] Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
    De Marchi, Tommaso
    Foekens, John A.
    Umar, Arzu
    Martens, John W. M.
    DRUG DISCOVERY TODAY, 2016, 21 (07) : 1181 - 1188
  • [5] Degree of Early Estrogen Response Predict Survival after Endocrine Therapy in Primary and Metastatic ER-Positive Breast Cancer
    Oshi, Masanori
    Tokumaru, Yoshihisa
    Angarita, Fernando A.
    Yan, Li
    Matsuyama, Ryusei
    Endo, Itaru
    Takabe, Kazuaki
    CANCERS, 2020, 12 (12) : 1 - 16
  • [6] Estrogen receptor (ER) and ER-related receptor expression in normal and atrophic human vagina
    Cavallini, Aldo
    Dinaro, Edoardo
    Giocolano, Alessandra
    Caringella, Anna Maria
    Ferreri, Roberto
    Tutino, Valeria
    Loverro, Giuseppe
    MATURITAS, 2008, 59 (03) : 219 - 225
  • [7] Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer
    Reinert, Tomas
    de Paula, Bruno
    Shafaee, Maryam Nemati
    Souza, Pedro Henrique
    Ellis, Matthew J.
    Bines, Jose
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (03)
  • [8] An immune-related signature for prediction of risk of late recurrences beyond proliferation and ER-related genes in ER-positive breast cancer.
    Bianchini, Giampaolo
    Rossi, Gabriella
    Callari, Maurizio
    Iwamoto, Takayuki
    Galeota, Eugenia
    Karn, Thomas
    Kelly, Catherine Margaret
    Zambetti, Milvia
    Rpia, Libero Santa
    Pusztai, Lajos
    Gianni, Luca
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Low Estrogen Receptor ( ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy Is Response Similar to Typical ER-Positive or ER-Negative Disease?
    Landmann, Alessandra
    Farrugia, Daniel J.
    Zhu, Li
    Diego, Emilia J.
    Johnson, Ronald R.
    Soran, Atilla
    Dabbs, David J.
    Clark, Beth Z.
    Puhalla, Shannon L.
    Jankowitz, Rachel C.
    Brufsky, Adam M.
    Ahrendt, Gretchen M.
    McAuliffe, Priscilla F.
    Bhargava, Rohit
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 (01) : 34 - 42
  • [10] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    Jordan, VC
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S4 - S4
12345